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Abstract
SIGNR1, a member of a new family of mouse C-type lectins, is expressed at high levels in
macrophages (M/) within the splenic marginal zone, lymph node medulla, and in some strains, in
peritoneal cavity. We previously reported that SIGNR1 captures gram-negative bacteria, such as
Escherichia coli and Salmonella typhimurium, as well as Candida albicans. We have now investigated
the precise ligands and innate responses that involve SIGNR1. The interaction of SIGNR1 with
FITC–dextran and E. coli was completely inhibited by LPS from E. coli and Salmonella minnesota.
Using LPS from various types of rough mutants of Salmonella, we found that SIGNR1 primarily
recognizes oligosaccharides in the non-reductive end of the LPS core region. In transfectants,
expression of SIGNR1 enhanced the oligomerization of Toll-like receptor (TLR) 4 molecules as well
as the degradation of IjB-a after stimulation with E. coli under low-serum conditions. The enhanced
TLR4 oligomerization was inhibited by pre-treatment of the cells with anti-SIGNR1 mAb or with
mannan. A physical association between SIGNR1 and the TLR4–MD-2 complex was also observed by
immunoprecipitation. Finally, we found that transfection of SIGNR1 into the macrophage-like
RAW264.7 cells resulted in significant augmentation of cytokine production. These results suggest
that SIGNR1 associates with TLR4 to capture gram-negative bacteria and facilitate signal transduction
to activate innate M/ responses.
Introduction
Most cell types in the body express C-type lectins, but
macrophages (M/) and dendritic cells (DCs) are of special
interest because of their major roles in innate immunity (1).
C-type lectins, which are pattern recognition molecules, can
internalize various glycosylated substances and microbes,
leading in vitro to clearance and presentation of antigens.
M/ and DCs express other pattern recognition molecules,
particularly Toll-like receptors (TLRs), which mediate innate
responses to various components of pathogens, e.g. LPS,
peptidoglycan, non-methylated CpG DNA and single- and
double-stranded viral RNA (2, 3).
Interest in M/ and DC lectins was enhanced by the
identification of human (h) DC-SIGN (CD209), a type II trans-
membrane lectin with a single C-terminus carbohydrate
recognition domain. This lectin interacts with several different
pathogens including several viruses [HIV-1 (4), HCV (5),
dengue virus (6, 7), CMV (8), Ebola virus (9), Sindbis virus
(10)] and other microbes [mycobacteria (11, 12), Leishmania
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(13) and candida species (14)]. Recently, we identified five
mouse homologues of hDC-SIGN (15) and demonstrated their
reactivities with microbial polysaccharides, including dextran
and mannan (16, 17). Among these new lectins, SIGNR1 is
abundant on particular subsets of M/ in the marginal zone of
spleen, the medulla of lymph nodes and in BALB/c mice, the
resident peritoneal cavity (17, 18), suggesting that SIGNR1+
M/ play a role as sentinels against pathogenic microbes.
In fact, SIGNR1 can capture encapsulated Streptococcus
pneumoniae in vivo (19, 20), and in culture recognizes
pathogenic Candida albicans, Escherichia coli and Salmo-
nella typhimurium (16).
Lipoarabinomannan from mycobacteria is a ligand for TLR2
that inhibits LPS-induced IL-12 production and enhances IL-10
production by human DCs. Lipoarabinomannan also targets
DC-SIGN (12) and the mannose receptor (MR) (21). Ligation of
blood dendritic cells antigen-2 (BDCA-2), a novel type II C-type
lectin that is primarily expressed on human plasmacyotid DCs,
suppressed type I IFN production induced by the TLR9 ligand,
CpG-oligodeoxynucleotides (22). Surfactant protein-A (SP-A),
which belongs to the collectin subgroup of C-type lectins,
down-regulates TLR2-mediated signaling and tumor necrosis
factor (TNF)-a secretion stimulated by zymosan, by attenuating
the binding of zymosan to TLR2 (23). In the case of the lectin,
dectin-1, a receptor for b-glucan, cooperation with TLR2 has
been shown to generate pro-inflammatory responses to fungal
pathogens (24, 25). All of these results indicate that two types of
pattern recognition receptors, lectins and TLRs, can interact at
the molecular level to positively and negatively regulate innate
cellular responses (26, 27).
In this report we will show that recognition of the non-
reductive portion of core polysaccharides of LPS on gram-
negative bacteria by SIGNR1 enhances TLR4-mediated
responses, such as TLR4 oligomerization, IjB-a degradation
and pro-inflammatory cytokine production. Pre-treatment of
SIGNR1-expressing cells with mannan or anti-SIGNR1 mAb
abrogates these responses, possibly through an observed
physical association between SIGNR1 and TLR4–MD-2 on the
plasma membrane.
Methods
Mice
Female BALB/c, C3H/HeN and C3H/HeJ mice were pur-
chased from Japan SLC (Hamamatsu, Shizuoka, Japan). The
mice were maintained under specific pathogen-free condition
and used at 8–12 weeks of age. All experiments were
conducted according to institutional guidelines.
Cells and cultures
Human embryonic kidney (HEK) 293T cells, Chinese hamster
ovary cells (CHO) and macrophage-like RAW264.7 cells were
maintained in DMEM containing 10% heat-inactivated FCS, 2
mM L-glutamine, 100 U ml1 penicillin and 100 lg ml1
streptomycin. RAW264.7 transfectants were maintained in 10
lg ml1 of blasticidin (Invitrogen, Carlsbad, CA, USA). The
mouse pro-B cell line Ba/F3 and its transfectants were
maintained in RPMI containing 10% FCS, 2 mM L-glutamine,
100 U ml1 penicillin, 100 lg ml1 streptomycin as well as
1/2000 volume of conditioned medium from the X63-mIL3 line
(28). The retrovirus packaging cell line PLAT-E, a kind gift
from Kitamura, University of Tokyo, was maintained in DMEM
containing 10% FCS, 2 mM L-glutamine, 1 lg ml1 puromycin
and 10 lg ml1 blasticidine. Resident peritoneal cells were
obtained by lavage of peritoneal cavity with 10 ml of ice-cold
PBS containing 5 mM EDTA. For the preparation of exudate
M/, mice were inoculated with either 2 ml of 10% proteose
peptone (PP) for 3 days, or 2 ml of 4% of thioglycollate
(TGC) (both from Difco, Detroit, MI, USA) for 4 days.
Flow cytometry analyses of peritoneal cells
Peritoneal cells were pre-incubated with anti-CD16/32 (2.4G2)
mAb for 30min to block FccR and then stained with PE–CD11b
(clone M1/70; BD PharMingen, San Diego, CA, USA) followed
by biotin–ER-TR9 (BMA Biomedicals, Augst, Switzerland)
(29) with streptavidin–Cy-Chrome (BD PharMingen) to detect
SIGNR1 expression. Biotin–DX5 (CD49b; BD PharMingen)
was used as an isotype-matched control of mouse IgM. To
analyze FITC–dextran binding, peritoneal cells stained with
PE–CD11b at (2 3 105 cells per well) were incubated with
80 lg ml1 of FITC–dextran (molecular weight, 2000 kDa;
Sigma–Aldrich, Irvine, CA, USA) in HBSS containing 1% BSA
and 0.1% NaN3 (HBSS-BSA) for 1 h at 4C. Flow cytometry
was performed on a FACSCalibur system (Becton Dickinson,
Mountain View, CA, USA) and analyzed by FlowJo software
(Tree Star Inc., San Carlos, CA, USA). To inhibit SIGNR1, Fc-
blocked resident peritoneal cells (1 3 105 cells per well) were
pre-incubated with ER-TR9 (25 lg ml1; Bachem Bioscience,
King of Prussia, PA, USA), control rat IgM (25 lg ml1; clone
R4-22; BD PharMingen), mannan (Sigma–Aldrich; from Sac-
charomyces cerevisiae; 1 mgml1), EDTA (20mM), E. coli LPS
(80 lg; smooth strain, serotype 0111: B4; Sigma–Aldrich) or
Salmonella minnesota LPS (80 lg; smooth strain, Sigma–
Aldrich) in HBSS-BSA. After a 1-h incubation on ice, cells were
further incubated with 80 lg ml1 of FITC–dextran for 1 h
followed by washing with HBSS-BSA. FITC–dextran binding
was analyzed by flow cytometry.
Inhibition of microbe binding with various types of LPS to
Ba/F3 transfectants
The cDNA-encoding SIGNR1 (15) was cloned into the
retrovirus vector pMX-puromycin (a kind gift from Kitamura,
University of Tokyo) (30). For virus production, the packaging
cell line PLAT-E (31) was transfected using FuGene (Roche
Diagnostics, Mannheim, Germany) according to the manufac-
turer’s protocol. Ba/F3 cells were infected with the virus
supernatant including 10lgml1 of polybrene (Sigma–Aldrich)
under centrifugation (3003 g) for 2 h at 32C. Cells expressing
SIGNR1 were obtained by limiting dilution. The Ba/F3 (23 105
cells) transfectants were then pre-treated with mannan (1 mg
ml1),E. coli LPS,S. minnesota LPS,S. typhimurium TV119LPS
(rough strain, Ra mutant), S. typhimurium SL684 LPS (Rc
mutant), S. typhimurium SL1181 LPS (Re mutant), 2-keto-3-
deoxy octonate (KDO) and lipid A from S. minnesota Re-595
(100 lg ll1; all from Sigma–Aldrich) as well as capsular
pneumococcal polysaccharide (CPS) type 3 and type 14
(100 lg ml1; both from American Type Culture Collection,
Manassas, VA, USA) in HBSS-BSA for 30 min on ice. Then the
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cells were further incubated with Alexa488-labeled E. coli
(Molecular Probes, Eugene, OR, USA; 23 105 particles) for 4 h
at 4C. After washing with PBS containing 1% FCS, cells were
analyzed by flow cytometry. To examine blocking efficiency,
SIGNR1 transfectants were pre-incubated with the graded
doses of LPS and CPS. Percent inhibition was calculated
according to the formula: [1  (percentage of SIGNR1
transfectant-binding microbe in the presence of inhibitor 
percentage of non-transfectant-binding microbe)/(percentage
of SIGNR1 transfectant-binding microbe percentage of non-
transfectant-binding microbe)] 3 100. Inhibitor itself did not
reduce E. coli binding of non-transfectant.
Detection of oligomerization of TLR4
Oligomerization of TLR4 after stimulation with E. coli was per-
formedasdescribed (32), usingBa/F3 transfectants (3~53107
cells) expressing TLR4-Flag, TLR4-GFP, MD-2Flag and
CD14 with or without SIGNR1. The cells were incubated
with 2% formalin-fixed E. coli (XL-1 Blue K-12 strain lacking
O-antigen; Stratagene, La Jolla, CA, USA) at various doses
in the presence or absence of serum. After incubation for
30 min at 37C, cells were lysed in 1 ml of lysis buffer 1 [50
mM Tris–HCl (pH 7.6), 150 mM NaCl, 25 mM CaCl2, 0.5%
Triton X-100, 1 mM phenylmethylsulphonylfluoride and 20
lg ml1 aprotinin] for 30 min on ice. The lysate was
incubated with 1 lg of anti-GFP (Molecular Probes)
antibody and 30 ll of Protein A/G agarose (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) for 12 h at 4C. Then
the agarose beads were washed twice with 1 ml of the lysis
buffer 1 and once with binding buffer (lysis buffer 1 without
Triton X-100) including 0.05% Triton X-100. Proteins bound
to the agarose beads were separated by 7.5% SDS-PAGE
under denaturing conditions, transferred to Immobilon-P
membrane (Millipore, Bedford, MA, USA), probed by HRP-
labeled anti-Flag (Sigma–Aldrich) or anti-Xpress antibody
(Invitrogen) with HRP–anti-mouse IgG (Amersham Biosci-
ence, Uppsala, Sweden) and visualized by LumiGLO
chemiluminescent substrate (Cell Signaling Technology,
Beverly, MA, USA) according to the manufacture’s proto-
cols. Precipitation of TLR4-GFP was confirmed using HRP–
anti-GFP antibody (Santa Cruz Biotechnology). For inhibition
assays, cells were incubated with hamster anti-SIGNR1
mAb (22D1) (20) or hamster IgG at 25 lg ml1 or mannan
at 100 lg ml1 for 30 min at 37C before the addition of
E. coli (XL-1 Blue).
IjB-a degradation assay
Ba/F3 transfectants (1 3 106 cells) expressing SIGNR1 alone,
or TLR4-Flag, TLR4-GFP, MD-2Flag and CD14 with or without
SIGNR1, were stimulated with formalin-fixed E. coli (XL-1 Blue)
at 37C in 1 ml of RPMI1640 containing 0.01% serum. Lysates
equivalent to 53 104 cells were separated by 10% SDS-PAGE
under denaturing conditions and subjected to western blot
analysis using anti-IjB-a (clone C-2; Santa Cruz Biotechnol-
ogy) followed by HRP-labeled goat anti-rabbit IgG.
Detection of an association of SIGNR1 with TLR4–MD-2
HEK 293T cells in 35-mm dishes were transiently transfec-
ted with pEFBOS/mTLR4flaghis, pEFBOS/mMD-2flaghis and
pcDNA4/HisMax-SIGNR1 tagged with Xpress at the N-
terminus as described (16). After 48 h, cells were harvested
and lysed in 1 ml of lysis buffer 1 for 30 min on ice. After
removing cell debris by centrifugation at 12 0003 g for 20min,
the lysate was diluted 10-fold with binding buffer, and one-
tenth was incubated with 1 lg of rabbit polyclonal anti-SIGNR1
(PAb-C13) (17), mouse anti-Xpress, rat anti-mTLR4–MD-2
complex (clone MTS510; eBioscience, San Diego, CA, USA)
or anti-Flag (clone M2; Sigma–Aldrich) along with 30 ll of
Protein A/G agarose. After a 12 h incubation at 4C, the
agarose beads were washed five times by 1 ml of the binding
buffer supplemented with 0.05% Triton X-100. Bound proteins
were subjected to western blot analysis with HRP-labeled anti-
Flag or anti-Xpress. In the case of Ba/F3 transfectants, 23 107
cells are subjected to immunoprecipitation with the rabbit
polyclonal PAb-C13 followed by detection using anti-Flag
antibody with HRP-labeled bovine anti-mIgG1 (clone AM6;
Cosmo Bio, Tokyo, Japan).
Cytokine production by RAW transfectants and resident
peritoneal M/ after E. coli stimulation
RAW264.7 cells were transfected with pcDNA4/HisMax or
pcDNA4/HisMax-SIGNR1 (16) by Lipofectamine 2000 (Invi-
trogen) in accordance with the manufacturer’s protocol.
RAW264.7 transfectants expressing SIGNR1 were obtained
by limiting dilution. The transfectants (5 3 105 cells per well)
were cultured overnight in serum-free medium, X-VIVO15
(BioWhittaker, Walkersville, MD, USA) and stimulated with
S. typhimurium KUB5001 (3 microbes per cell; clinically
isolated by Mitsuyama, Kyoto university) for 1 h at 37C. After
washing, cells were further incubated for 7 h at 37C. Resident
peritoneal M/ were negatively enriched by depletion of CD3-,
B220-, CD19-, Gr-1- and CD49b-expressing cells using
biotinylated mAbs with avidine–IMAg (BD PharMingen) and
stimulated at 1 E. coli to 10 M/ for 6 h at 37C in X-VIVO15
medium. Then culture supernatants were collected and
assessed for cytokine production using Cytometric Bead
Array for mouse inflammation kit (BD Biosciences, Franklin
Lakes, NJ, USA). For the inhibition assay, transfectants were
incubated with 25 lg ml1 of anti-SIGNR1 mAb (22D1) or
control hamster IgG for 30 min at 37C before the addition of
S. typhimurium.
Results
LPS inhibits FITC–dextran binding via SIGNR1
In a previous study, we demonstrated that SIGNR1 trans-
fectants captured gram-negative bacteria, such as E. coli and
S. typhimurium, as well as FITC–dextran (16). To examine the
possibility that SIGNR1 recognizes LPS on the bacterial outer
membrane, we conducted experiments to block FITC–dextran
binding to SIGNR1 with LPS, using peritoneal cells, of which
a fraction express SIGNR1 (16, 33). We first confirmed
SIGNR1 expression on resident peritoneal cells compared
with elicited M/ by PP and TGC (Fig. 1A). The results revealed
that SIGNR1 was expressed only on resident, but not elicited,
CD11b+ M/ and that neither of these elicited M/-bound FITC–
dextran. Binding of FITC–dextran to resident M/ was shown
to depend on SIGNR1, since it was completely abolished by
SIGNR1 enhances TLR4 response 829
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pre-incubation of M/ with ER-TR9 anti-SIGNR1 mAb, mannan
and EDTA (Fig. 1B). Furthermore, LPS from smooth strains of
E. coli and S. minnesota entirely abrogated FITC–dextran
binding. These results indicate that SIGNR1 can recognize
LPS of gram-negative bacteria.
The polysaccharide portion of LPS is crucial for the
recognition by SIGNR1
LPS binding was also tested using Ba/F3 cells expressing
SIGNR1 at 4C in HBSS supplemented with BSA to avoid
possible involvement of serum component, such as LPS-
binding protein (LBP). The Ba/F3 transfectants captured
fluoresceinated E. coli, and the binding was completely
blocked by pre-incubation with mannan (Fig. 2A), suggesting
that the polysaccharide on E. coli surface was recognized by
SIGNR1. As expected, microbial binding to SIGNR1 trans-
fectants was abolished by excess amounts of LPS (Fig. 2B). In
addition, the binding of E. coli was also inhibited by type 14,
but not type 3 CPS, being consistent with the prior observation
that type 14 CPS has much higher blocking activity for the
uptake of FITC–dextran via SIGNR1 (20). When blocking
efficiency for E. coli binding was compared, S. minnesota LPS
was equally potent to type 14 CPS and far more potent than
E. coli LPS (Fig. 2C).
To define the region of LPS recognized by SIGNR1, we
performed experiments to inhibit E. coli binding using various
types of LPS from rough mutants of S. typhimurium, since the
structure of the core region of LPS is shared by each other (34)
(Fig. 3A). As shown in Fig. 3(B), both LPS from the Ra mutant
that lacks O-antigen and mannan suppressed the binding of
E. coli, whereas LPS from the Rc and Re mutants as well as the
LPS components, KDO and lipid A, did not inhibit the binding.
Similarly, binding of zymosan to CHO cells transfected with
SIGNR1 was effectively suppressed by LPS from the smooth
strains and Ra mutant, but not by the others (data not shown).
SIGNR1 enhances TLR4 oligomerization upon stimulation
with E. coli
The TLR4–MD-2 complex is a crucial receptor for transducing
signals from LPS by recognizing lipid A in LPS in concert with
CD14 (35). The results in Fig. 3 had indicated that SIGNR1
recognizes the core polysaccharide portion, but not lipid A
of LPS, during binding of E. coli. To elucidate a potential role
of SIGNR1 for TLR4-mediated signaling, we used a newly
developed system to detect oligomerization of TLR4 mole-
cules after LPS stimulation (32). We transduced SIGNR1
cDNA into Ba/F3 cells expressing TLR4-Flag, TLR4-GFP, MD-
2Flag and CD14. The expression levels of the TLR4–MD-2
complex and CD14 were not affected by SIGNR1 expression
(Fig. 4A). In the presence of serum (0.5%), there were no
differences in TLR4 oligomerization regardless of the pres-
ence of SIGNR1 after stimulation with graded numbers of
E. coli (Fig. 4B, left panels). Similar results were obtained at
higher concentrations of serum (10%) and by stimulation with
LPS instead of E. coli (data not shown). However, under low-
serum conditions (0.01%), TLR4 oligomerization was hardly
detected in the transfectants lacking SIGNR1 (Fig. 3B, right
upper panel), whereas SIGNR1 transfectants were able to
oligomerize TLR4 in response to E. coli (Fig. 3B, right lower
panel). In contrast, only trace TLR4 oligomerization was
evident when 3 lg ml1 of LPS was used instead of E. coli
microbes (data not shown). SIGNR1-mediated TLR4 oligo-
merization by E. coli was also confirmed by blocking the
recognition of LPS with mannan and anti-SIGNR1 mAb (Fig.
4C). These results strongly suggest that SIGNR1 is involved in
TLR4–MD-2-mediated signaling particularly by microbes.
SIGNR1 enhances downstream signaling of TLR4 after
stimulation with E. coli
Next we examined TLR4–MD-2-mediated intracellular signal-
ing by analyzing IjB-a degradation in response to E. coli
Fig. 1. FITC–dextran binding by SIGNR1 on resident peritoneal M/ is
blocked by LPS. (A) Resident M/ specifically express SIGNR1 and
bind FITC–dextran. Resident, PP- or thioglycollate-elicited peritoneal
cells were stained by PE–anti-CD11b and anti-SIGNR1 antibody, ER-
TR9. SIGNR1 expression patterns of the CD11bhigh cells were
indicated as histograms (middle panels). Open histograms showed
staining patterns with control antibody. Binding of FITC–dextran by the
CD11bhigh cells is also depicted (right panels). After PE–anti-CD11b
staining, the peritoneal cells were incubated with FITC–dextran (80 lg
ml1) at 4C for 1 h. (B) Resident peritoneal cells were pre-incubated
with ER-TR9, control IgM (25 lg ml1 each), mannan (1 mg ml1),
EDTA (20 mM), Escherichia coli LPS (80 lg ml1) or Salmonella
minnesota (80 lg ml1) LPS for 30 min at 4C before adding FITC–
dextran. Histograms indicate FITC–dextran binding of the CD11bhigh
cells.
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under low-serum conditions. Following stimulation of trans-
fectants expressing TLR4–MD-2–CD14 and SIGNR1 with
E. coli (10 particles per cell), the level of IjB-a expression
was decreased to 27% at 30 min and recovered to 84% at
120 min, relative to unstimulated controls. However, there was
no decrease in the amount of IjB-a at any time point in
parental Ba/F3 cells with or without SIGNR1 (Fig. 5A). Upon
stimulation with a larger number of E. coli (20 particles per
cell), cells expressing TLR4–MD-2–CD14 and SIGNR1 ex-
hibited rapid and strong IjB-a degradation (40% at 10min and
13% at 30 min) and prompt recovery (91% at 120 min) (Fig.
5B). In parallel, cells expressing TLR4–MD-2–CD14 without
SIGNR1 showed significant degradation (44% at 30 min and
25% at 60 min) but slow recovery (29% at 120 min). These
results support the notion that SIGNR1 facilitates signal
transduction through TLR4–MD-2.
Association of SIGNR1 with TLR4–MD-2 complex
It has been shown that lung SP-A binds directly to TLR2 and
influences TNF-a production in response to the lectin ligands,
peptidoglycan (36) and zymosan (23). Thus, we analyzed the
interaction of SIGNR1 with the TLR4–MD-2 complex without
stimulation. Cell lysates of HEK 293T transfected with TLR4-
Flag-, MD-2Flag- and Xpress-tagged SIGNR1 were subject to
immunoprecipitation. The rabbit anti-SIGNR1 (PAb-C13) and
anti-Xpress antibodies co-precipitated TLR4 and MD-2, show-
ing an association of SIGNR1 with TLR4 and MD-2 (Fig. 6A).
Conversely, anti-Flag and MTS510 also co-precipitated
SIGNR1 (Fig. 6B). Using two independent stable transfectants
of Ba/F3, we confirmed the co-precipitation of SIGNR1 with
TLR4 and MD-2 (Fig. 6C). Since the MTS510 antibody is
specific for the TLR4–MD-2 complex, and TLR4 is only
Fig. 2. Binding of E. coli via SIGNR1 and its inhibition by LPS and
CPS. (A) Ba/F3 cells expressing SIGNR1 were incubated with
Alexa488-labeled E. coli at 4C for 4 h. Binding was analyzed by
flow cytometry. For inhibition assays, the transfectants were pre-
incubated with mannan (1 mg ml1) at 4C for 30 min. (B) Ba/F3 cells
expressing SIGNR1 and parent cells were pre-incubated with LPS
from E. coli or S. minnesota, or type 3 or type 14 CPS at 100 lg ml1 as
in (A). After washing, binding of Alexa488-labeled E. coli was analyzed
4 h later as described. (C) SIGNR1 transfectants and parental Ba/F3
cells were pre-incubated with the graded doses of LPS or CPS, and
then binding of Alexa488-labeled E. coli was analyzed as in (B).
Percent inhibition was calculated as described in Methods.
Fig. 3. SIGNR1 recognizes the core polysaccharide portion LPS
from gram-negative bacteria. (A) Structures of outer and inner core
region of LPS from S. typhimurium. Sugar components deleted from
LPS in various S. typhimurium rough mutants are shown. GlcNAc,
N-acetyl-glucosamine; Glc, glucose; Gal, galactose; Hep, L-glycero-
D-manno-heptose; KDO. (B) As in Fig. 3(A), transfectants were
pre-incubated with 100 lg ml1 of various types of LPS from rough
mutants, KDO, lipid A or 1 mg ml1 of mannan at 4C for 30 min.
Binding of Alexa488-labeled E. coli was analyzed.
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expressed on the cell surface by forming heterodimers with
MD-2 (37), SIGNR1 complexes with cell surface TLR4–MD-2.
SIGNR1 augments cytokine production of RAW264.7 and
resident peritoneal M/
To further analyze the role of SIGNR1 in cell activation, we
established macrophage-like RAW264.7 cells expressing
SIGNR1 by gene transfection and examined the cytokine
production following stimulation with S. typhimurium (3 mi-
crobes per cell) in serum-free medium. Unlike previous studies
of other C-type lectins, such as hDC-SIGN, MR, and BDCA-2
with TLR9, SIGNR1 markedly augmented the production of
IL-6, TNF-a and MCP-1 in response to microbial stimulation
(Fig. 7). The increased production of cytokines in SIGNR1-
transfected cells was inhibited by anti-SIGNR1 but not by
control IgG. In this system, IL-10 and IL-12p70 were below the
detection levels. It should be noted that mannan and type 14
CPS in liquid phase have no inhibitory effect on augmented
production of cytokines mediated by SIGNR1 (data not
shown). Anti-SIGNR1 also remarkably blocked cytokine
productions, including IL-10, of C3H/HeN resident peritoneal
M/ (Fig. 8). However, peritoneal M/ from C3H/HeJ mice,
which are defective in TLR4-mediated signaling, showed no
significant cytokine production by microbes, although they
express comparable levels of SIGNR1 to those fromC3H/HeN,
indicating that any TLRs other than TLR4 is not involved in
cytokine production induced by E. coli in association with
SIGNR1. These findings indicate that SIGNR1 can enhance
the TLR4-dependent innate cytokine response to microbes
in M/.
Discussion
Accumulating evidence indicates that C-type lectins, such
as hDC-SIGN, MR and BDCA-2, can deliver negative signals
that interfere with TLR-mediated cellular responses against
pathogens. In contrast, in the present study, we demonstrate
that SIGNR1, a mouse homologue of hDC-SIGN, recogni-
zes the core saccharide portion of LPS in gram-negative
bacteria and facilitates signal transduction and subsequent
pro-inflammatory cytokine production, possibly though an
Fig. 4. SIGNR1 enhances TLR4 oligomerization upon stimulation with
E. coli. (A) Ba/F3 transfectant expressing TLR4-Flag, TLR4-GFP, MD-
2Flag and CD14 was transduced with SIGNR1 gene and stained with
anti-SIGNR1 (ER-TR9), anti-TLR4–MD-2 (MTS510) or anti-CD14 (Sa2-
8). Open histograms represent staining profiles with control anti-
bodies. (B) Transfectants were stimulated with E. coli at various
numbers of microbes for 30 min at serum concentrations indicated.
The cell lysates were subjected to immunoprecipitation with anti-GFP
for TLR4. Co-precipitation of TLR4-Flag was detected by western
blotting with anti-Flag. Precipitation of TLR-GFPwas confirmed by anti-
GFP antibody. (C) The transfectants prepared in (A) were pre-treated
with mannan, hamster IgG or anti-SIGNR1 (22D1), followed by
stimulation with E. coli in the presence of 0.01% serum.
Fig. 5. SIGNR1 enhances IjB-a degradation after stimulation with
E. coli. Escherichia coli bacteria were added to cell cultures at 10 and
20 microbes per cell in (A) and (B), respectively. After incubation for
various time periods in the presence of 0.01% serum, IjB-a and b-
actin in whole-cell lysates were analyzed by western blotting.
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observed physical association between SIGNR1 and TLR4–
MD-2 complex on the plasma membrane.
In a previous paper, we reported that only SIGNR1, but
not several other homologues of hDC-SIGN, bound gram-
negative bacteria (16). This binding activity of SIGNR1 is now
found to be directed to the LPS from a rough strain (K-12
E. coli) and a smooth strain (clinically isolated S. typhimurium).
The outermost component of LPS is called O-antigen, which
is a polymer of O-subunits. Each O-subunit is typically
composed of four to six sugars depending on the particular
O-antigen. Variation in the O-antigen results from a variation in
the sugar components of the O-subunit, including a variation in
the nature of the covalent bond between the sugars of the
subunit, and a variation in the nature of the linkage between
the O-subunits that form the O-antigen polymer (38, 39).
In addition, the E. coli K-12 strain used in this study lacks
O-antigen. Therefore, it is unlikely that the O-antigen is
recognized by SIGNR1.
Bacteria in the Enterobacteriaceae family include E. coli
and S. typhimurium and have similar but not identical core
polysaccharides (34). We took advantage of this and used
commercially available LPS from rough mutant strains of
S. typhimurium to define the sugars responsible for interac-
tions with SIGNR1. Our results revealed that SIGNR1
recognizes the non-reductive outer end of the core poly-
saccharide of LPS. Oligosaccharide structures of this portion
in S. typhimurium and S. minnesota are [GlcNAc]GlcGal
(40, 41), whereas the corresponding oligosaccharide struc-
ture of E. coli K-12 is [GlcNAcHep]GlcGlc (34). These
differences in the oligosaccharide structure between E. coli
and S. typhimurium and S. minnesota possibly account for
their different efficiencies for inhibiting microbial binding, as
seen in Fig. 2(B and C). In addition, the LPS of the Rc mutant
Fig. 7. Augmented cytokine production by the macrophage-like cell
line, RAW264.7, via SIGNR1 in response to S. typhimurium. RAW264.7
transfectants (53 105 cells per well) were cultured overnight in serum-
free medium, X-VIVO15, and stimulated with S. typhimurium (3
microbes per cell) for 1 h at 37C. After washing, cells were further
incubated for 7 h at 37C. For the inhibition assay, cells were pre-
treated with 25 lgml1 of anti-SIGNR1 (clone 22D1) or control hamster
IgG for 30 min at 37C before the addition of microbes. Then culture
supernatants were collected and assessed for inflammatory cytokine
production using Cytometric Bead Array.
Fig. 6. Association of SIGNR1 with the TLR4–MD-2 complex. (A) Cell
lysates of 293T transiently transfected with pEFBOS/mTLR4flaghis,
pEFBOS/mMD-2flaghis and pcDNASIGNR1 (Xpress tagged) were
subjected to immunoprecipitation with antibodies indicated, followed
by western blot analyses by anti-Flag antibody against TLR4-Flag and
MD-2Flag. (B) As in (A), cell lysates were precipitated with anti-Flag or
anti-TLR4–MD-2 complex (MTS510), followed by blotting SIGNR1-
Xpress using anti-Xpress antibody. (C) Cell lysates of stable Ba/F3
transfectants expressing TLR4-Flag, MD-2Flag and SIGNR1 was
precipitated with anti-SIGNR1 (PAb-C13), followed by western blot
analysis using anti-Flag antibody. Numbers indicate two independent
clones.
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lacking [GlcNAc]GlcGal was not inhibitory at all (Fig. 3B). We
have also observed in the previous study that GlcNAc was
inhibitory for FITC–dextran uptake by SIGNR1 (16). Therefore,
SIGNR1 most likely recognizes GlcNAc or [GlcNAc]Glc in the
oligosaccharide. During the preparation of the manuscript, it
was reported that hDC-SIGN recognizes the non-reductive
end of E. coli LPS using HeLa cells expressing hDC-SIGN and
various strains of E. coli (42). Their results demonstrate that
hDC-SIGN recognized E. coli K-12, but not waaR mutant
bacteria lacking oligosaccharide [GlcNAcHep]Glc at the non-
reductive end of the core polysaccharide. Together, there may
be a common mechanism for the recognition of gram-negative
bacteria by SIGNR1 and hDC-SIGN.
SIGNR1 expression clearly augments TLR4 oligomerization
and IjB-a degradation in response to microbes, but only when
serum concentration was limiting (Figs 4 and 5). In the
absence of SIGNR1, TLR4 oligomerization was observed in
the presence of serum (Fig. 4B), whereas little or no TLR4
oligomerization was detected in the absence of serum, unless
SIGNR1 was also co-expressed. We do not yet understand
the basis for this serum effect, but in the absence of serum, the
cooperation with SIGNR1 possibly occurs through the ob-
served constitutive association between SIGNR1 and TLR4–
MD-2 on the plasma membrane (Fig. 6). However, SIGNR1
showed no augmentative effect on TLR4 oligomerization of Ba/
F3 cells expressing TLR4–MD-2 but lacking CD14, a receptor
of LBP (data not shown), although SIGNR1 associated with the
TLR4–MD-2 complex in the absence of CD14. As in the case of
TLR4–MD-2 (32), SIGNR1 was not detected to physically
associate with CD14 in the presence or absence of microbial
or LPS stimulation (data not shown). In addition, microbial
stimulation did not significantly enhance association of
SIGNR1 and TLR4–MD-2 (data not shown). CD14 and LBP
are well known to be crucial for effective transfer of LPS to
TLR4–MD-2 complex (35). Therefore, it is not conceivable that
the lipid A portion in LPS bound to SIGNR1 is directly
transferred to the TLR4–MD-2 complex without the aid of
CD14. Molecular mechanisms underlying LPS transfer from
CD14 with LBP in concert with SIGNR1 remain to be
elucidated. However, these results suggest a possible in-
teraction of SIGNR1 with CD14 on the plasma membrane. Our
observation that SIGNR1 expression substantially augmented
pro-inflammatory cytokine production during culture in serum-
free medium (Fig. 7) may support this possibility.
Notably, anti-SIGNR1 mAb blocked the augmentation in
cytokine production by bacteria (Figs 7 and 8). However, pre-
treatment with type 14 CPS andmannan in liquid phase had no
inhibitory effect on cytokine production mediated by SIGNR1
(data not shown), even though these agents effectively
blocked E. coli binding (Fig. 2). The reasons for this apparent
discrepancy in the blocking of cytokine production and
microbial binding are not clear. One possibility is the
temperature for the assay: the binding assay takes place at
4C, whereas cytokine production occurs at 37C after pre-
incubation with blocking agents. Temperature affects mem-
brane fluidity, leading to the association/dissociation of
molecules. Cross-linking with anti-SIGNR1 mAb causes rapid
internalization of SIGNR1 molecules from the cell surface,
resulting in depletion of functional SIGNR1 molecules. Another
possibility is the difference in affinity of SIGNR1 for blocking
agents relative to the microbe of S. typhimurium. Specific mAb
once bound to an epitope is not dissociated under phy-
sical conditions, but the situation is different in the case of
competitive inhibitors.
Accumulating evidence is revealing that TLR-mediated
signaling and cell activation are regulated by various C-type
Fig. 8. SIGNR1-dependent cytokine production induced by E. coli. C3H/HeN- and C3H/HeJ-derived resident peritoneal M/ enriched negatively
by magnetic beads were stimulated with E. coli at 1 microbe per 10 cells in X-VIVO15 medium for 6 h, and cytokine activities in culture
supernatants were assessed by Cytometric Bead Array. Inhibition assay was carried out as in Fig. 7.
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lectins (12, 21–25). Prior to this study, SIGNR1 has been
thought to primarily act as an endocytotic receptor but not
to transduce signals in cell activation, since SIGNR1 has no
putative signaling motif in its cytoplasmic tail except for
a dileucine motif to form clathrin-coated pit for endocytosis
(15, 16). Neither ligation by anti-SIGNR1 mAb (22D1) nor
stimulation with mannan and type 14 CPS induced cytokine
production by RAW264.7 expressing SIGNR1 (data not
shown), so it appears that a ligand, e.g. the microbe, must
have components that can be recognized by both SIGNR1
and TLR4. Precise molecular mechanisms that augment TLR-
mediated signals are currently being investigated.
The virulence of gram-negative bacteria is known to depend
on the O-antigen that confers the resistance to complement-
mediated killing and phagocytosis (43–45). Interestingly,
Klena et al. proposed that O-antigen serves as an anti-
phagocytic factoring by blocking the hDC-SIGN-mediated
contact of the ligand with the host (42). However, our previous
study demonstrated that smooth strains of Salmonella with
O-antigen as well as zymosan could be phagocytosed by
COS-7 cells expressing SIGNR1 (16). Therefore, a possibility
still remains that SIGNR1, unlike hDC-SIGN, is able to recog-
nize part of O-antigen. Taken altogether, under physiological
conditions, SIGNR1 may rapidly capture gram-negative
bacteria to internalize and sequester the microbe from
inducing an excessive response through the LBP and
TLR4–MD-2 complex, but also supports signal transduction
for innate defense.
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Abbreviations
CPS capsular pneumococcal polysaccharide
DC dendritic cell
DC-SIGN dendritic cell-specific intercellular adhesion molecule
3-grabbing nonintegrin binding receptor
HEK human embryonic kidney
hDC-SIGN human DC-SIGN
KDO 2-keto-3-deoxy octonate
LBP LPS-binding protein
M/ macrophages
MR mannose receptor
PP proteose peptone
SP-A surfactant protein-A
TGC thioglycollate
TLR Toll-like receptor
TNF tumor necrosis factor
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